Search Results - ALGAZY, KENNETH

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

    Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck by BAUMAN, JESSICA, LANGER, COREY, QUON, HARRY, ALGAZY, KENNETH, LIN, ALEXANDER, DESAI, ARATI, MUTALE, FAITH, WEISS, JARED

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    A single-institution comparison of cetuximab, carboplatin, and paclitaxel induction chemotherapy followed by chemoradiation (CRT) versus CRT for locally-advanced squamous cell carcinoma of the head and neck (LA-SCCHN)

    A single-institution comparison of cetuximab, carboplatin, and paclitaxel induction chemotherapy followed by chemoradiation (CRT) versus CRT for locally-advanced squamous cell carc... by Grover, Surbhi, Mitra, Nandita, Wan, Fei, Lukens, J. Nicholas, Sharma, Sonam, Bauman, Jessica, Masroor, Farzad, Cohen, Roger B., Desai, Arati, Algazy, Kenneth, Alonso-Basanta, Michelle, Ahn, Peter, Teo, Boon-Keng Kevin, Chalian, Ara, Weinstein, Gregory S., O’Malley, Bert W., Lin, Alexander

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m(2) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

    A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m(2) for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer by Fury, Matthew G., Sherman, Eric, Lisa, Donna, Agarwal, Neeraj, Algazy, Kenneth, Brockstein, Bruce, Langer, Corey, Lim, Dean, Mehra, Ranee, Rajan, Sandeep K., Korte, Susan, Lipson, Brynna, Yunus, Furhan, Tanvetyanon, Tawee, Smith-Marrone, Stephanie, Ng, Kenneth, Xiao, Han, Haque, Sofia, Pfister, David G.

    Published 2012
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

    Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma by Rangwala, Reshma, Chang, Yunyoung C, Hu, Janice, Algazy, Kenneth M, Evans, Tracey L, Fecher, Leslie A, Schuchter, Lynn M, Torigian, Drew A, Panosian, Jeffrey T, Troxel, Andrea B, Tan, Kay-See, Heitjan, Daniel F, DeMichele, Angela M, Vaughn, David J, Redlinger, Maryann, Alavi, Abass, Kaiser, Jonathon, Pontiggia, Laura, Davis, Lisa E, O’Dwyer, Peter J, Amaravadi, Ravi K

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: